Intervention Review

Buprenorphine for the management of opioid withdrawal

  1. Linda Gowing*,
  2. Robert Ali,
  3. Jason M White

Editorial Group: Cochrane Drugs and Alcohol Group

Published Online: 8 JUL 2009

Assessed as up-to-date: 17 NOV 2008

DOI: 10.1002/14651858.CD002025.pub4

Database Title

Additional Information

How to Cite

Gowing L, Ali R, White JM. Buprenorphine for the management of opioid withdrawal. Cochrane Database of Systematic Reviews 2009, Issue 3. Art. No.: CD002025. DOI: 10.1002/14651858.CD002025.pub4.

Author Information

  1. University of Adelaide, Discipline of Pharmacology, Adelaide, South Australia, Australia

*Linda Gowing, Discipline of Pharmacology, University of Adelaide, Frome Road, Adelaide, South Australia, 5005, Australia. linda.gowing@adelaide.edu.au.

Publication History

  1. Publication Status: New search for studies and content updated (conclusions changed)
  2. Published Online: 8 JUL 2009

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (57K)Standard (773K)Full (823K)

  1. Current Version

    Buprenorphine for the management of opioid withdrawal

    Linda Gowing, Robert Ali and Jason M White

    Article first published online: 8 JUL 2009 | DOI: 10.1002/14651858.CD002025.pub4

Previous versions of this article and their online publication dates

  1. Version 3

    Buprenorphine for the management of opioid withdrawal

    Linda Gowing, Robert Ali and Jason M White

    Article first published online: 15 APR 2009 | DOI: 10.1002/14651858.CD002025.pub3

  2. Version 2

    Buprenorphine for the management of opioid withdrawal

    L Gowing, R Ali and J White

    Article first published online: 25 JAN 2006 | DOI: 10.1002/14651858.CD002025.pub2

  3. Version 1

    Buprenorphine for the management of opioid withdrawal

    L Gowing, R Ali and J White

    Article first published online: 19 JUL 2004 | DOI: 10.1002/14651858.CD002025

View Full Article (HTML) Summary (57K)Standard (773K)Full (823K)